Follow
Subscribe via Email!

Enter your email address to subscribe to this platform and receive notifications of new posts by email.

Male-Centric Medical Data Risks Deepening Healthcare AI Bias

Decades of medical trials treated male bodies as standard, leaving women underrepresented in clinical data. As artificial intelligence learns from these historical records, algorithmic tools risk perpetuating diagnostic disparities and unequal treatments.
CPR training manikin used in medical resuscitation education.

Concerns over healthcare AI bias are mounting as hospitals integrate predictive algorithms trained on historical patient records. Can predictive models trained on decades of male-centered clinical records deliver equitable care to women? When medical systems adopt algorithmic diagnostic tools without scrutinizing historical data gaps, previous exclusions become automated standards. In England, ambulance service figures reported in 2024 revealed that fewer than one in 12 patients for whom resuscitation was attempted survived 30 days [12].

CPR Manikins and the Male Standard

Emergency response training offers a tangible physical illustration of male-centered medical defaults. Most healthcare professionals and citizens learn cardiopulmonary resuscitation on flat-chested manikins. Three-quarters of the manikin models sold worldwide in a 2024 survey lacked female anatomical features. Researchers evaluated 20 commercial manikin models and discovered that only a single product offered an attachable breast overlay. The missing female anatomy reflects a persistent clinical tendency to view the male body as the human baseline. Physical absence reinforces psychological hesitation among first responders during real emergencies [12].

Cardiac arrest registries confirm that physical training disparities carry severe clinical consequences when sudden medical emergencies occur in public settings. In an American study examining 19,331 out-of-hospital cardiac events published in Circulation: Cardiovascular Quality and Outcomes, only 39% of women who collapsed in public received bystander cardiopulmonary resuscitation, compared with 45% of men [1]. Bystander hesitation rapidly reduces survival. An investigation led by Nguyen and colleagues in 2024 demonstrated that patients who received bystander resuscitation between four and five minutes after witnessed cardiac arrest faced 27% lower odds of surviving to hospital discharge than individuals treated within 60 seconds [2]. Every passing minute without chest compressions diminishes recovery chances.

The disparity costs lives. Hesitation rooted in anatomical unfamiliarity reduces prompt public intervention, directly depressing female resuscitation rates before emergency ambulances arrive [1, 2].

How Healthcare AI Bias Learns Clinical Habits

Modern healthcare algorithms learn statistical associations from historical electronic health records rather than unmediated biological realities. Clinical documentation captures human medical decisions together with objective pathology. If clinicians historically evaluated male and female patients differently when diagnosing identical symptoms, algorithmic networks detect those discrepancies and encode them as predictive clinical rules. Medical algorithms absorb diagnostic habits and present historical inequities as objective clinical patterns. Without proactive corrective measures, unchecked healthcare AI bias solidifies outdated clinical habits into permanent diagnostic protocols across hospital networks.

An experimental investigation published in Health Psychology by Chiaramonte and Friend demonstrates how human diagnostic habits introduce distortions into clinical archives. When coronary heart disease symptoms coincided with psychological stress, medical students and resident physicians assigned women significantly fewer coronary heart disease diagnoses and fewer cardiology referrals than men. Assessors frequently dismissed female cardiovascular distress as psychogenic (originating from psychological rather than organic biological factors) [3]. An artificial intelligence system trained on records produced under these practices interprets reduced female cardiology referrals as evidence that women require less cardiovascular intervention.

Commercial clinical algorithms rarely disclose their underlying demographic training distributions. A 2024 regulatory review examining 692 medical devices approved by the Food and Drug Administration revealed that demographic distributions and clinical validation studies were routinely omitted from public documentation [11]. Exploring how philosophers guiding artificial intelligence address ethical oversight highlights the necessity of inspecting algorithmic assumptions. Algorithms repeat past decisions. Addressing healthcare AI bias requires inspecting training archives before deployment.

CPR training manikin illustrating how male physiological defaults can inform healthcare AI bias.
A standard CPR training manikin used in emergency resuscitation instruction. (Credit: Medical Xpress)

Exclusion Policies That Made Men the Default

Female bodies were systematically excluded from clinical research for decades because researchers viewed hormonal cycles as inconvenient noise. Following the severe birth defects caused by thalidomide during the late 1950s and early 1960s, the Food and Drug Administration issued guidance in 1977 recommending the exclusion of women with childbearing potential from phase I drug trials. Although the regulatory agency reversed that policy in 1993, commercial trials continued excluding pregnant women [4]. Federal drug trial policies entrenched the young male body as the standard subject of pharmacology. The exclusion persisted.

Preclinical laboratory investigations mirrored clinical trial exclusions by favoring male animal models and male cell lines. Researchers often avoided female rodents under the assumption that estrous cycles introduced confounding biological variability, despite empirical evidence showing female animals exhibit no greater variance than males [11]. In cell biology, Shah, McCormack, and Bradbury reported in the American Journal of Physiology-Cell Physiology that many basic science publications failed to document the biological sex of experimental cells [5]. Even elaborate brain cell maps in primates demonstrate that cellular diversity requires precise demographic and biological characterization. Basic biological datasets systematically obscured female cellular pathways.

Researchers treated hormonal shifts as confounding experimental noise. Can machine learning models overcome the absence of female biology when historical training data never recorded it? By isolating male physiology as the experimental baseline, biomedical science accumulated decades of foundational datasets that reflect only half the human population [11]. This systemic omission fuels healthcare AI bias across modern predictive architectures.

Pharmacology Gaps and Adverse Drug Reactions

Excluding female physiology from pharmacological trials produced tangible therapeutic failures in clinical practice. The sleep medication zolpidem provides one of the clearest documented examples of metabolic divergence. Women clear the compound from their circulation considerably slower than men, maintaining elevated morning blood concentrations that impair motor skills and driving ability. In 2013, the Food and Drug Administration responded to pharmacokinetic data by recommending that manufacturers halve the recommended starting dose for female patients [6]. Dosage differences matter.

Zolpidem exposes broader pharmacological neglect. An extensive meta-analysis by Zucker and Prendergast published in Biology of Sex Differences demonstrated that women experience adverse drug reactions nearly twice as often as men across diverse therapeutic classes. The authors established that sex differences in pharmacokinetics (the physiological processes of drug absorption, distribution, metabolism, and elimination) explain the majority of these severe clinical events [7]. Because initial dosage recommendations derived from male cohorts, women routinely received disproportionately high drug concentrations.

Predictive algorithms deployed to optimize medication regimens frequently overlook sex-specific pharmacokinetic variations. If clinical software calculates dosing schedules from aggregated historical trial reports, healthcare AI bias can perpetuate improper pharmacological dosing for female patients. Algorithmic systems lack biological awareness unless model architects explicitly program sex-specific metabolic parameters into predictive calculations [7, 11].

Medical research setting where historical male-centric trial data generates healthcare AI bias.
Clinical research documentation reflecting historical imbalances between male and female subject participation. (Credit: The Conversation)

Symptom Disparities in Heart Attacks and Strokes

Diagnostic criteria defined around male physiology frequently mislead clinical staff when women present with life-threatening acute conditions. In a systematic review and meta-analysis published in the Journal of the American Heart Association, van Oosterhout and colleagues evaluated symptom presentations across more than 1 million patients suffering from acute coronary syndromes. While 74% of women and 79% of men reported central chest pain, women exhibited significantly higher odds of presenting with neck pain, jaw pain, fatigue, and shortness of breath [9]. Does an absence of typical chest pain explain delayed triage in emergency rooms? Emergency triage often falters.

Stroke triage reveals comparable clinical delays. An Australian clinical study reviewing more than 202,000 hospital admissions found that women under 70 who arrived at emergency departments by ambulance were less likely than men to receive a preliminary stroke diagnosis from paramedics. Furthermore, emergency responders were less likely to enroll these female patients under the prehospital stroke protocol (a standardized emergency paramedic assessment) [11]. When diagnostic protocols define standard disease presentations exclusively around male baselines, clinicians fail to recognize critical vascular events in female patients.

Differences in medical presentation extend across nationwide demographic registries. A comprehensive epidemiological investigation of 6.9 million citizens in Denmark revealed that women were systematically older than men at the time of their first hospital diagnosis across most medical conditions [11]. Diagnostic delays and atypical symptom presentations compound historical data gaps in emergency medicine. These diagnostic oversights contribute directly to healthcare AI bias when historical admission records train risk scoring models.

Designing Transparent Healthcare AI Systems

Correcting clinical bias requires precise demographic data. In 2016, international editors published the SAGER guidelines (Sex and Gender Equity in Research) to standardize demographic reporting in scientific literature [8]. Nevertheless, compliance remains fragmented across modern biomedical literature. A 2026 systematic review of 574 medical studies discovered that while 61% included both male and female subjects, only 44% performed dedicated analyses disaggregated by sex [11]. Equal participation is not enough.

Brittany Vining and Suzannah Williams authored an analysis of these systemic disparities available as a preprint, which has not yet undergone formal peer review [10]. Vining and Williams argue that training algorithmic healthcare tools on historical clinical records risks entrenching healthcare AI bias into automated diagnostic systems. Scientific editors Lisa Lock and Andrew Zinin at Medical Xpress emphasized that healthcare databases frequently collapse biological sex and cultural gender into a single binary variable, obscuring distinct physiological mechanisms and access barriers [12]. Without granular data architectures, predictive algorithms cannot decouple biological vulnerability from clinical bias.

Building dependable clinical models demands that data scientists interrogate whether observed health disparities reflect underlying biology or inequitable care patterns. If future software models merely replicate archival decision patterns, healthcare AI bias will continue to misdiagnose underrepresented cohorts. Careful computational design can empower machine learning algorithms to identify subtle diagnostic patterns that human medicine historically overlooked, ensuring that predictive healthcare serves all patients equitably [10, 11]. Equitable care demands precision.

Sources
  1. ACADEMIC JOURNAL Blewer, A. L., McGovern, S. K., Schmicker, R. H., May, S., Morrison, L. J., Aufderheide, T. P., Daya, M., Idris, A. H., Callaway, C. W., Kudenchuk, P. J., Vilke, G. M., Abella, B. S., & Resuscitation Outcomes Consortium (ROC) Investigators (2018). Gender Disparities Among Adult Recipients of Bystander Cardiopulmonary Resuscitation in the Public. Circulation: Cardiovascular Quality and Outcomes, 11(8). [Article Link]
  2. ACADEMIC JOURNAL Nguyen, D. D., Spertus, J. A., Kennedy, K. F., Gupta, K., Uzendu, A. I., McNally, B. F., & Chan, P. S. (2024). Association Between Delays in Time to Bystander CPR and Survival for Witnessed Cardiac Arrest in the United States. Circulation: Cardiovascular Quality and Outcomes, 17(2). [Article Link]
  3. ACADEMIC JOURNAL Chiaramonte, G. R., & Friend, R. (2006). Medical students’ and residents’ gender bias in the diagnosis, treatment, and interpretation of coronary heart disease symptoms. Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 25(3), 255-66. [Article Link]
  4. ACADEMIC JOURNAL Shields, K. E., & Lyerly, A. D. (2013). Exclusion of pregnant women from industry-sponsored clinical trials. Obstetrics and gynecology, 122(5), 1077-1081. [Article Link]
  5. ACADEMIC JOURNAL Shah, K., McCormack, C. E., & Bradbury, N. A. (2014). Do you know the sex of your cells?. American Journal of Physiology-Cell Physiology, 306(1), C3-C18. [Article Link]
  6. ACADEMIC JOURNAL Farkas, R. H., Unger, E. F., & Temple, R. (2013). Zolpidem and Driving Impairment — Identifying Persons at Risk. New England Journal of Medicine, 369(8), 689-691. [Article Link]
  7. ACADEMIC JOURNAL Zucker, I., & Prendergast, B. J. (2020). Sex differences in pharmacokinetics predict adverse drug reactions in women. Biology of Sex Differences, 11(1). [Article Link]
  8. ACADEMIC JOURNAL Heidari, S., Babor, T. F., De Castro, P., Tort, S., & Curno, M. (2016). Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use. Research Integrity and Peer Review, 1(1). [Article Link]
  9. ACADEMIC JOURNAL van Oosterhout, R. E. M., de Boer, A. R., Maas, A. H. E. M., Rutten, F. H., Bots, M. L., & Peters, S. A. E. (2020). Sex Differences in Symptom Presentation in Acute Coronary Syndromes: A Systematic Review and Meta‐analysis. Journal of the American Heart Association, 9(9). [Article Link]
  10. PREPRINT Vining, B., & Williams, S. (2026). Decades of male-focused medical research could bias healthcare AI [Preprint – not peer reviewed]. [Article Link]
  11. ONLINE NEWS Vining, B., & Williams, S. (2026, September 17). Decades of male-focused medical research could bias healthcare AI. The Conversation. [Article Link]
  12. ONLINE NEWS Lock, L., & Zinin, A. (2026, September 17). Decades of male‑focused medical research could bias health care AI. Medical Xpress. [Article Link]
Cite this page

APA 7: TWs Editor. (2026, September 18). Male-Centric Medical Data Risks Deepening Healthcare AI Bias. PerEXP Teamworks. https://perexpteamworks.com/en/healthcare-ai-bias-medical-research/

Leave a Comment

Related Posts
Total
0
Share